South Africa says it can't afford anti-AIDS drug AZT.
D000163:Acquired Immunodeficiency Syndrome; D000349:Africa; D017954:Africa South of the Sahara; D000353:Africa, Southern; D003362:Cost-Benefit Analysis; D003906:Developing Countries; D004194:Disease; D005069:Evaluation Studies as Topic; D006076:Government; D015658:HIV Infections; D004364:Pharmaceutical Preparations; D011057:Politics; D013019:South Africa; D013812:Therapeutics; D014777:Virus Diseases
D004364:Pharmaceutical Preparations
Acquired Immunodeficiency Syndrome--prevention and control; Africa; Africa South Of The Sahara; Cost Effectiveness; Developing Countries; Diseases; Drugs--cost; English Speaking Africa; Evaluation; Evaluation Indexes; Government; Hiv Infections--prevention and control; Political Factors; Quantitative Evaluation; South Africa; Southern Africa; Treatment; Viral Diseases